FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W207875344> ?p ?o ?g. }

• W207875344 endingPage "20" @default.
• W207875344 startingPage "314" @default.
• W207875344 abstract "Anthracyclines and taxanes are the most active agents in the adjuvant treatment of breast cancer (BC). They can be used simultaneously or sequentially. The optimal schedule and duration for their administration is unknown. We analyzed the efficacy of sequential adjuvant anthracycline and docetaxel administration in node positive BC patients.Node positive BC patients (N=539) from 6 medical oncology centers in Turkey who received sequential adjuvant anthracycline-based regimens and taxane chemotherapy were included in this study between 2006 - 2010. One-hundred and thirty-eight (25%) patients received 3 cycles of anthracycline-based chemotherapy followed by 3 cycles of docetaxel (3+3) and 401 (75%) patients received 4 cycles of anthracycline-based chemotherapy followed by 4 cycles of docetaxel (4+4). Prognostic factors analyzed were estrogen receptor (ER), progesterone receptor (PR), HER2, tumor grade, and nodal status in relation to disease free survival (DFS) and HER2 status in relation to overall survival (OS).The patient median age was 48 years (range 18-79). Most common grade 3-4 toxicities were neutropenia, mucositis and arthralgia. No treatment-related toxic deaths were seen. With a median follow up of 26 months (range 1-115) 61 (11.3%) recurrences and 11 (2%) deaths were registered. Three-year DFS was 81% and OS 96% for all patients. There was no statistically significant difference between 3+3 and 4+4 groups in terms of survival (3-year DFS 88% and 79% [p=0.28] and OS 97% and 95% [p=0.60), respectively).Sequential chemotherapy with 4+4 cycles of anthracycline and docetaxel every 3 weeks is an acceptable regimen for adjuvant treatment of node positive BC patients. Duration of chemotherapy should be planned depending on prognostic factors. In this study there was no difference between 3+3 and 4+4 groups in DFS and OS despite the presence of good prognostic factors in the 3+3 group." @default.
• W207875344 created "2016-06-24" @default.
• W207875344 creator A5000554665 @default.
• W207875344 creator A5029436367 @default.
• W207875344 creator A5034419246 @default.
• W207875344 creator A5045696675 @default.
• W207875344 creator A5052748672 @default.
• W207875344 creator A5055483190 @default.
• W207875344 creator A5066403117 @default.
• W207875344 creator A5071630168 @default.
• W207875344 creator A5074696453 @default.
• W207875344 creator A5075330567 @default.
• W207875344 creator A5083256086 @default.
• W207875344 creator A5087681632 @default.
• W207875344 date "2013-07-03" @default.
• W207875344 modified "2023-10-16" @default.
• W207875344 title "Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study." @default.
• W207875344 cites W1994502729 @default.
• W207875344 cites W2033274910 @default.
• W207875344 cites W2049174093 @default.
• W207875344 cites W2072281109 @default.
• W207875344 cites W2084370697 @default.
• W207875344 cites W2098333537 @default.
• W207875344 cites W2120639027 @default.
• W207875344 cites W2123129045 @default.
• W207875344 cites W2127232551 @default.
• W207875344 cites W2135800076 @default.
• W207875344 cites W2138440511 @default.
• W207875344 cites W2141056749 @default.
• W207875344 cites W2146406055 @default.
• W207875344 cites W2150706560 @default.
• W207875344 cites W2335332412 @default.
• W207875344 cites W2597616474 @default.
• W207875344 cites W72909911 @default.
• W207875344 cites W957937196 @default.
• W207875344 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23818340" @default.
• W207875344 hasPublicationYear "2013" @default.
• W207875344 type Work @default.
• W207875344 sameAs 207875344 @default.
• W207875344 citedByCount "1" @default.
• W207875344 countsByYear W2078753442016 @default.
• W207875344 crossrefType "journal-article" @default.
• W207875344 hasAuthorship W207875344A5000554665 @default.
• W207875344 hasAuthorship W207875344A5029436367 @default.
• W207875344 hasAuthorship W207875344A5034419246 @default.
• W207875344 hasAuthorship W207875344A5045696675 @default.
• W207875344 hasAuthorship W207875344A5052748672 @default.
• W207875344 hasAuthorship W207875344A5055483190 @default.
• W207875344 hasAuthorship W207875344A5066403117 @default.
• W207875344 hasAuthorship W207875344A5071630168 @default.
• W207875344 hasAuthorship W207875344A5074696453 @default.
• W207875344 hasAuthorship W207875344A5075330567 @default.
• W207875344 hasAuthorship W207875344A5083256086 @default.
• W207875344 hasAuthorship W207875344A5087681632 @default.
• W207875344 hasConcept C121608353 @default.
• W207875344 hasConcept C126322002 @default.
• W207875344 hasConcept C143998085 @default.
• W207875344 hasConcept C2776694085 @default.
• W207875344 hasConcept C2776802502 @default.
• W207875344 hasConcept C2777063308 @default.
• W207875344 hasConcept C2777511904 @default.
• W207875344 hasConcept C2781190966 @default.
• W207875344 hasConcept C530470458 @default.
• W207875344 hasConcept C71924100 @default.
• W207875344 hasConceptScore W207875344C121608353 @default.
• W207875344 hasConceptScore W207875344C126322002 @default.
• W207875344 hasConceptScore W207875344C143998085 @default.
• W207875344 hasConceptScore W207875344C2776694085 @default.
• W207875344 hasConceptScore W207875344C2776802502 @default.
• W207875344 hasConceptScore W207875344C2777063308 @default.
• W207875344 hasConceptScore W207875344C2777511904 @default.
• W207875344 hasConceptScore W207875344C2781190966 @default.
• W207875344 hasConceptScore W207875344C530470458 @default.
• W207875344 hasConceptScore W207875344C71924100 @default.
• W207875344 hasIssue "2" @default.
• W207875344 hasLocation W2078753441 @default.
• W207875344 hasOpenAccess W207875344 @default.
• W207875344 hasPrimaryLocation W2078753441 @default.
• W207875344 hasRelatedWork W1036613081 @default.
• W207875344 hasRelatedWork W181195935 @default.
• W207875344 hasRelatedWork W1966804628 @default.
• W207875344 hasRelatedWork W2046284161 @default.
• W207875344 hasRelatedWork W2155611965 @default.
• W207875344 hasRelatedWork W2183543225 @default.
• W207875344 hasRelatedWork W2339380041 @default.
• W207875344 hasRelatedWork W2591616149 @default.
• W207875344 hasRelatedWork W3030794620 @default.
• W207875344 hasRelatedWork W3143244965 @default.
• W207875344 hasVolume "18" @default.
• W207875344 isParatext "false" @default.
• W207875344 isRetracted "false" @default.
• W207875344 magId "207875344" @default.
• W207875344 workType "article" @default.